Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | IT (& TMT) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Oncology |
Investing | United States |
Concord Health Partners is a healthcare-focused venture capital firm based in New York. Founded in 2017, they specialize in equity investment in expansion-stage companies. With expertise in leveraging technology and solutions, their goal is to enhance the value of healthcare by promoting lower costs, improved quality, and expanded access to care. Their investment portfolio spans across various sub-sectors such as healthcare services, healthcare information technology, medical technology, medical devices, diagnostics, and healthcare business support services. On their website, Concord Health Partners emphasizes their commitment to investing in companies with innovative technologies and solutions that advance healthcare through operational efficiencies, improved patient outcomes, and expanded access to care. They seek strong management teams to partner with to build leading healthcare companies. Their website explains their partnership model, which focuses on aligned incentives and the establishment of a broad network of strategic relationships. Concord Health Partners prides itself on healthcare sector specialization and deep industry knowledge. The firm denotes the Greek letter lambda in their logo to symbolize their dedication to creating strong partnerships with aligned interests, ensuring all parties are on the 'same wavelength.' With a notable track record since inception, the firm and its team of professionals bring over 17 years of healthcare experience to their 17 portfolio companies. They are located at 920 Broadway, 15th Floor, New York, and have an additional contact location at 25 Deforest Avenue, Suite 108, Summit, NJ.